Thomas D. Giles

15.4k total citations · 4 hit papers
288 papers, 10.9k citations indexed

About

Thomas D. Giles is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Thomas D. Giles has authored 288 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Cardiology and Cardiovascular Medicine, 59 papers in Endocrinology, Diabetes and Metabolism and 41 papers in Physiology. Recurrent topics in Thomas D. Giles's work include Blood Pressure and Hypertension Studies (101 papers), Hormonal Regulation and Hypertension (42 papers) and Heart Rate Variability and Autonomic Control (41 papers). Thomas D. Giles is often cited by papers focused on Blood Pressure and Hypertension Studies (101 papers), Hormonal Regulation and Hypertension (42 papers) and Heart Rate Variability and Autonomic Control (41 papers). Thomas D. Giles collaborates with scholars based in United States, United Kingdom and Sweden. Thomas D. Giles's co-authors include F. Xavier Pi‐Sunyer, Yuling Hong, Paul Poirier, George A. Bray, Judith S. Stern, Robert H. Eckel, Gary E. Sander, William B. White, Keith C. Ferdinand and Bonita Falkner and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Thomas D. Giles

278 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

2005 2.4k citations Thomas D. Giles et al. profile →
Resistant Hypertension: Diagnosis, Evaluation, and Treatment

2008 1.7k citations William B. White, Thomas D. Giles et al. profile →
Resistant Hypertension: Diagnosis, Evaluation, and Treatment

2008 1.0k citations William B. White, Thomas D. Giles et al. profile →
Obesity and Cardiovascular Disease

2006 588 citations Thomas D. Giles et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas D. Giles United States	40	6.3k	2.3k	1.9k	1.6k	1.2k	288	10.9k
Ehud Grossman Israel	54	5.2k 0.8×	2.2k 1.0×	1.3k 0.7×	1.5k 0.9×	1.1k 0.9×	400	10.3k
Leopoldo Raij United States	60	5.8k 0.9×	2.4k 1.1×	3.7k 1.9×	1.7k 1.1×	2.0k 1.6×	202	14.6k
Jacqueline C.M. Witteman Netherlands	54	4.2k 0.7×	2.0k 0.9×	1.4k 0.7×	1.6k 1.0×	1.4k 1.2×	92	12.7k
Frej Fyhrquist Finland	42	7.5k 1.2×	3.5k 1.6×	1.8k 0.9×	1.4k 0.9×	1.7k 1.4×	228	12.5k
Uri Goldbourt Israel	62	5.4k 0.8×	2.5k 1.1×	1.9k 1.0×	2.4k 1.5×	951 0.8×	323	13.5k
Christopher J. Bulpitt United Kingdom	55	8.9k 1.4×	3.1k 1.4×	1.5k 0.8×	1.7k 1.1×	754 0.6×	187	15.2k
Gianpaolo Reboldi Italy	52	8.1k 1.3×	2.3k 1.0×	1.4k 0.7×	2.0k 1.2×	1.6k 1.3×	259	14.3k
Timothy M. Morgan United States	56	4.5k 0.7×	1.9k 0.8×	1.5k 0.8×	1.6k 1.0×	627 0.5×	138	11.4k
Anthony M. Heagerty United Kingdom	56	10.4k 1.6×	3.0k 1.3×	2.7k 1.4×	3.0k 1.9×	1.9k 1.5×	280	15.9k
Stanley S. Franklin United States	49	8.8k 1.4×	2.7k 1.2×	971 0.5×	1.8k 1.1×	550 0.4×	137	12.6k

Countries citing papers authored by Thomas D. Giles

Since Specialization

Citations

This map shows the geographic impact of Thomas D. Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Giles more than expected).

Fields of papers citing papers by Thomas D. Giles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Giles. The network helps show where Thomas D. Giles may publish in the future.

Co-authorship network of co-authors of Thomas D. Giles

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas D. Giles. A scholar is included among the top collaborators of Thomas D. Giles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas D. Giles. Thomas D. Giles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sander, Gary E., Camilo Fernandez, Philip J. Kadowitz, & Thomas D. Giles. (2016). Sodium-Glucose Co-transporter 2 Inhibitor: A Perspective on Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus. 2(3). 139–144.

Giles, Thomas D., Gary E. Sander, Bobby D. Nossaman, & Philip J. Kadowitz. (2012). Impaired Vasodilation in the Pathogenesis of Hypertension: Focus on Nitric Oxide, Endothelial‐Derived Hyperpolarizing Factors, and Prostaglandins. Journal of Clinical Hypertension. 14(4). 198–205. 157 indexed citations

Giles, Thomas D., Thomas R. Alessi, Das Purkayastha, & Dion Zappe. (2012). Comparative Efficacy of Aliskiren/Valsartan vs Valsartan in Nocturnal Dipper and Nondipper Hypertensive Patients: A Pooled Analysis. Journal of Clinical Hypertension. 14(5). 299–306. 4 indexed citations

Giles, Thomas D.. (2007). Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.. PubMed. 8 Suppl 2. S14–21. 14 indexed citations

Weber, Michael A. & Thomas D. Giles. (2006). Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?. PubMed. 7(2). 45–54. 42 indexed citations

Giles, Thomas D.. (2005). Relevance of blood pressure variation in the circadian onset of cardiovascular events. Journal of Hypertension. 23(Suppl 1). S35–S39. 44 indexed citations

Hildebrandt, Per, Kristian Wachtell, Björn Dahlöf, et al.. (2005). Impairment of cardiac function in hypertensive patients with Type 2 diabetes: a LIFE study. Diabetic Medicine. 22(8). 1005–1011. 11 indexed citations

Bakris, George L., David H.G. Smith, Thomas D. Giles, et al.. (2005). Comparative Antihypertensive Efficacy of Angiotensin Receptor Blocker‐Based Treatment in African‐American and White Patients. Journal of Clinical Hypertension. 7(10). 587–597. 14 indexed citations

Giles, Thomas D., Kanu Chatterjee, Jay N. Cohn, et al.. (2004). Definition, classification, and staging of the adult cardiomyopathies: A proposal for revision. Journal of Cardiac Failure. 10(1). 6–8. 5 indexed citations

10.

Ćhilton, Robert, Edmund Kenneth Kerut, Dimitrios Charalampidis, et al.. (2004). 1006-57 Atherosclerotic plaque can be quantified using multifractal and wavelet decomposition techniques. Journal of the American College of Cardiology. 43(5). A34–A34. 1 indexed citations

11.

Agarwal, Pradeep, Gary E. Sander, & Thomas D. Giles. (2004). Treatment of Erectile Dysfunction in the Elderly With Phosphodiesterase Type 5 Inhibitors: Cardiovascular Implications. The American Journal of Geriatric Cardiology. 13(6). 332–335. 1 indexed citations

12.

Sander, Gary E. & Thomas D. Giles. (2003). Diabetes Mellitus and Heart Failure. The American Heart Hospital Journal. 1(4). 273–280. 21 indexed citations

13.

Giles, Thomas D.. (2002). Use of beta-blockers for heart failure in patients with diabetes mellitus.. PubMed. 112(5 Suppl Unanswered). 32–7. 3 indexed citations

14.

Sander, Gary E., et al.. (2002). Noncardiac Drugs and QTc Interval Prolongation: An Often Unrecognized Risk Factor for Adverse Cardiovascular Outcomes. The American Journal of Geriatric Cardiology. 11(3). 197–202.

15.

Kerut, Edmund Kenneth, William T. Norfleet, Gary D. Plotnick, & Thomas D. Giles. (2001). Patent foramen ovale: a review of associated conditions and the impact of physiological size. Journal of the American College of Cardiology. 38(3). 613–623. 288 indexed citations

16.

Giles, Thomas D.. (1997). Pharmacologic and clinical perspectives on mibefradil : a new T-channel selective calcium antagonist. 1 indexed citations

17.

Kerut, Edmund Kenneth, et al.. (1997). Detection of Right to Left Shunts in Decompression Sickness in Divers. The American Journal of Cardiology. 79(3). 377–378. 31 indexed citations

18.

Fifer, Michael A., César Molina, Antonio C. Quiroz, et al.. (1990). Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. The American Journal of Cardiology. 65(3). 211–216. 58 indexed citations

19.

Sander, Gary E., et al.. (1990). Efficacy of Nicardipine in Angina Pectoris. The Journal of Clinical Pharmacology. 30(1). 24–28. 2 indexed citations

20.

Giles, Thomas D., Richard J. Katz, Jay M. Sullivan, et al.. (1989). Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. Journal of the American College of Cardiology. 13(6). 1240–1247. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact